Table 3.
Survival analysis of patients with r-NENs and hepatic metastases treated by different methods.
| Treatment modalities | Overall survival rates (%) | Median OS (months) | Cancer-specific survival rates (%) | Median CSS (months) | ||||
|---|---|---|---|---|---|---|---|---|
| 1-year | 3-year | 5-year | 1-year | 3-year | 5-year | |||
| Surgery of the primary cancer | ||||||||
| Nonsurgical | 29.8 | 10.4 | 1.5 | 8 | 32.1 | 11.7 | 1.7 | 8 |
| Local resection | 84.6 | 76.9 | 41.2 | 47 | 84.6 | 76.9 | 48.1 | 47 |
| Radical resection | 72.0 | 43.7 | 43.7 | 29 | 72.0 | 43.7 | 43.7 | 29 |
| Radiotherapy | ||||||||
| No | 41.8 | 23.2 | 10.8 | 10 | 43.7 | 24.2 | 12.0 | 10 |
| Yes | 35.3 | 13.2 | 13.2 | 9 | 38.2 | 16.3 | 16.3 | 10 |
| Chemotherapy | ||||||||
| No | 57.1 | 34.1 | 19.9 | 20 | 60.4 | 36.1 | 23.7 | 24 |
| Yes | 32.8 | 15.4 | 7.3 | 9 | 34.3 | 16.8 | 7.9 | 9 |